Mirror Feedback, Augmented Task-Specific, Impairment-Oriented Therapy, Home Practice, Stroke Rehabilitation
The Effects of Mirror Feedback Augmented Task-Specific and Impairment-Oriented Therapy With Home Practice in Stroke Rehabilitation
1 other identifier
interventional
21
1 country
2
Brief Summary
In this study, the investigators will (1) examine immediate and long-term effects of MT priming with task-specific training versus MT-priming with impairment-oriented training, relative to a dose-matched control therapy on motor function, arm activities, quality of life, etc; (2) provide comprehensive evaluations based on the ICF model to identify the specific benefits of MT-priming regimens; and (3) explore demographic and clinical characteristics of participants that may predict treatment outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2021
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 18, 2021
CompletedFirst Posted
Study publicly available on registry
July 27, 2021
CompletedStudy Start
First participant enrolled
July 29, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2022
CompletedJune 25, 2024
August 1, 2022
1 year
July 18, 2021
June 23, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Change from Baseline Fugl-Meyer Assessment (FMA) at 6 weeks, and 18 weeks
The upper-extremity subscale of the FMA will be used to assess motor impairment. FMA contains 33 items (scale 0-66). The higher summed score means the greater recovery of motor impairment.
Baseline, 6 weeks, and 18 weeks
Change from Baseline Motor Activity Log (MAL) at 6 weeks, and 18 weeks
The MAL is a subjective outcome measure of an individual's real life functional upper limb performance. The MAL is administered by semi-structured interview to determine (a) how much (Amount of Use - AOU), and (b) how well the individual uses his upper limb (Quality of Movement - QOM) in real life.
Baseline, 6 weeks and 18 weeks
Secondary Outcomes (5)
Change from Baseline Nottingham Extended Activities of Daily Living Scale (NEADL) at 6 weeks, and 18 weeks
Baseline, 6 weeks and 18 weeks
Change from Baseline Stroke Impact Scale Version 3.0 (SIS 3.0) at 6 weeks, and 18 weeks
Baseline, 6 weeks, and 18 weeks
Change from Baseline Wolf Motor Function Test (WMFT) score at 6 weeks
Baseline and 6 weeks
Change from Baseline Grip and Pinch strength at 6 weeks
Baseline and 6 weeks
Change from Baseline Chedoke Arm and Hand Activity Inventory (CAHAI) at 6 weeks
Baseline and 6 weeks
Study Arms (3)
Mirror therapy (MT) priming with task-specific training
EXPERIMENTALIn the regimen, participants will perform MT first followed by task-specific training. After completion of MT, participants will practice task-specific training that emphasizes on restoration of essential skills for daily activities. After that, the contents of home practice will be designed corresponding to treatment principles of the clinic-based intervention.
Mirror therapy priming with impairment-oriented training
ACTIVE COMPARATORIn the regimen, participants will perform MT first followed by impairment-oriented training. After completion of MT, participants will practice impairment-oriented training that emphasizes on restoration of movement. After that, the contents of home practice will be designed corresponding to treatment principles of the clinic-based intervention.
Control therapy
ACTIVE COMPARATORThe control group will receive therapeutic training equivalent in duration to the two experimental groups. The control intervention will include practice of gross/fine motor activities, training of activities of daily living, practice to increase range of motions, muscle strengthening, as well as use of adaptive or compensatory technique to alleviate functional deficits. After that, the contents of home practice will be designed corresponding to treatment principles of the clinic-based intervention.
Interventions
In the regimen, participants will perform MT first followed by task-specific training. After completion of MT, participants will practice task-specific training that emphasizes on restoration of essential skills for daily activities. After that, the contents of home practice will be designed corresponding to treatment principles of the clinic-based intervention.
In the regimen, participants will perform MT first followed by impairment-oriented training. After completion of MT, participants will practice impairment-oriented training that emphasizes on restoration of movement. After that, the contents of home practice will be designed corresponding to treatment principles of the clinic-based intervention.
The control group will receive therapeutic training equivalent in duration to the two experimental groups. The control intervention will include practice of gross/fine motor activities, training of activities of daily living, practice to increase range of motions, muscle strengthening, as well as use of adaptive or compensatory technique to alleviate functional deficits. After that, the contents of home practice will be designed corresponding to treatment principles of the clinic-based intervention.
Eligibility Criteria
You may qualify if:
- A first ever-stroke≧3 months
- Baseline Fugl-Meyer assessment of upper extremity scale (FMA-UE) between 18 to 56 (Fugl-Meyer et al. 1975)
- No excessive muscle spasticity of the affected arm (Modified Ashworth Scale \< 3 at any joints of the affected arm) (Bohannon \& Smith 1987)
- Able to follow examiners' commands and study instructions (Mini-Mental State Examination score≧22) (Folstein et al. 1975)
- No participation in any other experimental rehabilitation or drug studies during period of this project
You may not qualify if:
- Concomitant neurologic, neuromuscular or orthopedic conditions that may interfere with participation of this project
- Epilepsy within three months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Feng Yuan Hospital
Taichung, Taiwan
National Taiwan University Hosipital
Taipei, 100, Taiwan
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Keh-chung Lin, ScD
School of Occupational Therapy, National Taiwan University, Taipei, Taiwan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 18, 2021
First Posted
July 27, 2021
Study Start
July 29, 2021
Primary Completion
July 31, 2022
Study Completion
July 31, 2022
Last Updated
June 25, 2024
Record last verified: 2022-08